Sly Saint
Senior Member (Voting Rights)
As millions of people grapple with COVID-19 infections, the medical community has learned more about the symptoms associated with periods of acute illness and the unpredictable path toward recovery. In this article, I’ll explain why a debilitating condition known as long-haul COVID will likely be one of the biggest insurance claims battlegrounds in the next few years.
The insurance battleground
Long-haul COVID symptoms can be debilitating and disabling. Some people previously in the workforce have discovered that a return to work is not yet possible after they have exhausted short-term disability benefits and/or no longer qualify for federal programs such as the Canada Emergency Response Benefit (CERB) or the Canada Recovery Benefit (CRB).
But many long-term disability insurers have been increasingly giving their insureds the run-around as they apply for these benefits. The reasons for delays or denials often have to do with the novelty of this illness and ongoing discussions within the medical community to define the syndrome’s symptoms or, indeed, to determine whether it is a new pathophysiological syndrome or psychosomatic.
In the personal injury field, sadly, we’ve heard this story before. Countless individuals suffering from a novel or previously little-understood conditions such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), fibromyalgia, chronic Epstein–Barr virus or post-treatment Lyme disease syndrome have fought for years for medical recognition of their genuine symptoms and resulting disabilities. When the medical community is still establishing the criteria for a condition or syndrome and there is no official diagnosis, insurers may point to a lack of medical consensus or evidence to deny a claim.
full article here
https://www.thelawyersdaily.ca/arti...r-long-haul-covid-19-and-long-term-disability